Experts discuss the importance of initiating blinatumomab treatment for acute lymphoid leukemia in academic centers for ...

A novel tool created by researchers at Weill Cornell Medicine and the University of Adelaide has improved the capacity to ...

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...

The results highlight an in vivo patient-derived xenograft (PDX) model of relapsed/refractory T-PLL that reproduced key human clinicopathological features of the disease. In this model, SLS009 ...

This research is still in the early stages, but it provides an exciting look at how cancer treatment could evolve. If future ...

Hundreds of people once again grabbed lanterns (and rain jackets) to once again to Light The Night in Portland.

Last year, state epidemiologists studied an industrialized region east of Houston. They reported finding high rates of cancer but refused to release key geographic details — a decision some experts ...

NRIX stock is rated Strong Buy as bexobrutideg advances in CLL trials. See here for NRIX stock's milestones, market potential ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

At a memorial service in 2022, veteran Air Force Capt. Monte Watts bumped into a fellow former Minuteman III nuclear missile ...

President Donald Trump shakes hands with AstraZeneca CEO Pascal Soriot in the Oval Office of the White House, Friday, Oct. 10 ...